Report Detail

Service & Software Global Biopharmaceutical CMO & CRO Market Size, Status and Forecast 2019-2025

  • RnM3412828
  • |
  • 20 July, 2020
  • |
  • Global
  • |
  • 128 Pages
  • |
  • QYResearch
  • |
  • Service & Software

Biopharmaceutical CMO & CRO market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biopharmaceutical CMO & CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Lonza
Boehringer Ingelheim GmbH
Rentschler Biotechnologie GmbH
Inno Biologics Sdn Bhd
JRS Pharma
BIOMEVA GmbH
ProBioGen
FUJIFILM Diosynth Biotechnologies USA., Inc.
TOYOBO CO., LTD
Samsung BioLogics
Patheon
CMC Biologics
Binex Co., Ltd.
AbbVie Inc.
WuXi Biologics

Market segment by Type, the product can be split into
Mammalian
Non-mammalian
Market segment by Application, split into
Contract Manufacturing
Contract Research

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Biopharmaceutical CMO & CRO Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Biopharmaceutical CMO & CRO Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Mammalian
    • 1.4.3 Non-mammalian
  • 1.5 Market by Application
    • 1.5.1 Global Biopharmaceutical CMO & CRO Market Share by Application: 2020 VS 2026
    • 1.5.2 Contract Manufacturing
    • 1.5.3 Contract Research
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Biopharmaceutical CMO & CRO Market Perspective (2015-2026)
  • 2.2 Global Biopharmaceutical CMO & CRO Growth Trends by Regions
    • 2.2.1 Biopharmaceutical CMO & CRO Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Biopharmaceutical CMO & CRO Historic Market Share by Regions (2015-2020)
    • 2.2.3 Biopharmaceutical CMO & CRO Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Biopharmaceutical CMO & CRO Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Biopharmaceutical CMO & CRO Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Biopharmaceutical CMO & CRO Players by Market Size
    • 3.1.1 Global Top Biopharmaceutical CMO & CRO Players by Revenue (2015-2020)
    • 3.1.2 Global Biopharmaceutical CMO & CRO Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Biopharmaceutical CMO & CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Biopharmaceutical CMO & CRO Market Concentration Ratio
    • 3.2.1 Global Biopharmaceutical CMO & CRO Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CMO & CRO Revenue in 2019
  • 3.3 Biopharmaceutical CMO & CRO Key Players Head office and Area Served
  • 3.4 Key Players Biopharmaceutical CMO & CRO Product Solution and Service
  • 3.5 Date of Enter into Biopharmaceutical CMO & CRO Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Biopharmaceutical CMO & CRO Historic Market Size by Type (2015-2020)
  • 4.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)
  • 5.2 Global Biopharmaceutical CMO & CRO Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Biopharmaceutical CMO & CRO Market Size (2015-2020)
  • 6.2 Biopharmaceutical CMO & CRO Key Players in North America (2019-2020)
  • 6.3 North America Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
  • 6.4 North America Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Biopharmaceutical CMO & CRO Market Size (2015-2020)
  • 7.2 Biopharmaceutical CMO & CRO Key Players in Europe (2019-2020)
  • 7.3 Europe Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
  • 7.4 Europe Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)

8 China

  • 8.1 China Biopharmaceutical CMO & CRO Market Size (2015-2020)
  • 8.2 Biopharmaceutical CMO & CRO Key Players in China (2019-2020)
  • 8.3 China Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
  • 8.4 China Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Biopharmaceutical CMO & CRO Market Size (2015-2020)
  • 9.2 Biopharmaceutical CMO & CRO Key Players in Japan (2019-2020)
  • 9.3 Japan Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
  • 9.4 Japan Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Biopharmaceutical CMO & CRO Market Size (2015-2020)
  • 10.2 Biopharmaceutical CMO & CRO Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)

11 India

  • 11.1 India Biopharmaceutical CMO & CRO Market Size (2015-2020)
  • 11.2 Biopharmaceutical CMO & CRO Key Players in India (2019-2020)
  • 11.3 India Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
  • 11.4 India Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Biopharmaceutical CMO & CRO Market Size (2015-2020)
  • 12.2 Biopharmaceutical CMO & CRO Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Biopharmaceutical CMO & CRO Market Size by Type (2015-2020)
  • 12.4 Central & South America Biopharmaceutical CMO & CRO Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Lonza
    • 13.1.1 Lonza Company Details
    • 13.1.2 Lonza Business Overview
    • 13.1.3 Lonza Biopharmaceutical CMO & CRO Introduction
    • 13.1.4 Lonza Revenue in Biopharmaceutical CMO & CRO Business (2015-2020))
    • 13.1.5 Lonza Recent Development
  • 13.2 Boehringer Ingelheim GmbH
    • 13.2.1 Boehringer Ingelheim GmbH Company Details
    • 13.2.2 Boehringer Ingelheim GmbH Business Overview
    • 13.2.3 Boehringer Ingelheim GmbH Biopharmaceutical CMO & CRO Introduction
    • 13.2.4 Boehringer Ingelheim GmbH Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 13.2.5 Boehringer Ingelheim GmbH Recent Development
  • 13.3 Rentschler Biotechnologie GmbH
    • 13.3.1 Rentschler Biotechnologie GmbH Company Details
    • 13.3.2 Rentschler Biotechnologie GmbH Business Overview
    • 13.3.3 Rentschler Biotechnologie GmbH Biopharmaceutical CMO & CRO Introduction
    • 13.3.4 Rentschler Biotechnologie GmbH Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 13.3.5 Rentschler Biotechnologie GmbH Recent Development
  • 13.4 Inno Biologics Sdn Bhd
    • 13.4.1 Inno Biologics Sdn Bhd Company Details
    • 13.4.2 Inno Biologics Sdn Bhd Business Overview
    • 13.4.3 Inno Biologics Sdn Bhd Biopharmaceutical CMO & CRO Introduction
    • 13.4.4 Inno Biologics Sdn Bhd Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 13.4.5 Inno Biologics Sdn Bhd Recent Development
  • 13.5 JRS Pharma
    • 13.5.1 JRS Pharma Company Details
    • 13.5.2 JRS Pharma Business Overview
    • 13.5.3 JRS Pharma Biopharmaceutical CMO & CRO Introduction
    • 13.5.4 JRS Pharma Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 13.5.5 JRS Pharma Recent Development
  • 13.6 BIOMEVA GmbH
    • 13.6.1 BIOMEVA GmbH Company Details
    • 13.6.2 BIOMEVA GmbH Business Overview
    • 13.6.3 BIOMEVA GmbH Biopharmaceutical CMO & CRO Introduction
    • 13.6.4 BIOMEVA GmbH Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 13.6.5 BIOMEVA GmbH Recent Development
  • 13.7 ProBioGen
    • 13.7.1 ProBioGen Company Details
    • 13.7.2 ProBioGen Business Overview
    • 13.7.3 ProBioGen Biopharmaceutical CMO & CRO Introduction
    • 13.7.4 ProBioGen Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 13.7.5 ProBioGen Recent Development
  • 13.8 FUJIFILM Diosynth Biotechnologies USA., Inc.
    • 13.8.1 FUJIFILM Diosynth Biotechnologies USA., Inc. Company Details
    • 13.8.2 FUJIFILM Diosynth Biotechnologies USA., Inc. Business Overview
    • 13.8.3 FUJIFILM Diosynth Biotechnologies USA., Inc. Biopharmaceutical CMO & CRO Introduction
    • 13.8.4 FUJIFILM Diosynth Biotechnologies USA., Inc. Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 13.8.5 FUJIFILM Diosynth Biotechnologies USA., Inc. Recent Development
  • 13.9 TOYOBO CO., LTD
    • 13.9.1 TOYOBO CO., LTD Company Details
    • 13.9.2 TOYOBO CO., LTD Business Overview
    • 13.9.3 TOYOBO CO., LTD Biopharmaceutical CMO & CRO Introduction
    • 13.9.4 TOYOBO CO., LTD Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 13.9.5 TOYOBO CO., LTD Recent Development
  • 13.10 Samsung BioLogics
    • 13.10.1 Samsung BioLogics Company Details
    • 13.10.2 Samsung BioLogics Business Overview
    • 13.10.3 Samsung BioLogics Biopharmaceutical CMO & CRO Introduction
    • 13.10.4 Samsung BioLogics Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 13.10.5 Samsung BioLogics Recent Development
  • 13.11 Patheon
    • 10.11.1 Patheon Company Details
    • 10.11.2 Patheon Business Overview
    • 10.11.3 Patheon Biopharmaceutical CMO & CRO Introduction
    • 10.11.4 Patheon Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 10.11.5 Patheon Recent Development
  • 13.12 CMC Biologics
    • 10.12.1 CMC Biologics Company Details
    • 10.12.2 CMC Biologics Business Overview
    • 10.12.3 CMC Biologics Biopharmaceutical CMO & CRO Introduction
    • 10.12.4 CMC Biologics Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 10.12.5 CMC Biologics Recent Development
  • 13.13 Binex Co., Ltd.
    • 10.13.1 Binex Co., Ltd. Company Details
    • 10.13.2 Binex Co., Ltd. Business Overview
    • 10.13.3 Binex Co., Ltd. Biopharmaceutical CMO & CRO Introduction
    • 10.13.4 Binex Co., Ltd. Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 10.13.5 Binex Co., Ltd. Recent Development
  • 13.14 AbbVie Inc.
    • 10.14.1 AbbVie Inc. Company Details
    • 10.14.2 AbbVie Inc. Business Overview
    • 10.14.3 AbbVie Inc. Biopharmaceutical CMO & CRO Introduction
    • 10.14.4 AbbVie Inc. Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 10.14.5 AbbVie Inc. Recent Development
  • 13.15 WuXi Biologics
    • 10.15.1 WuXi Biologics Company Details
    • 10.15.2 WuXi Biologics Business Overview
    • 10.15.3 WuXi Biologics Biopharmaceutical CMO & CRO Introduction
    • 10.15.4 WuXi Biologics Revenue in Biopharmaceutical CMO & CRO Business (2015-2020)
    • 10.15.5 WuXi Biologics Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Summary:
    Get latest Market Research Reports on Biopharmaceutical CMO & CRO. Industry analysis & Market Report on Biopharmaceutical CMO & CRO is a syndicated market report, published as Global Biopharmaceutical CMO & CRO Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Biopharmaceutical CMO & CRO market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,088.80
    4,633.20
    6,177.60
    3,611.40
    5,417.10
    7,222.80
    590,265.00
    885,397.50
    1,180,530.00
    325,260.00
    487,890.00
    650,520.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report